MERCK & CO., INC. (MRK)
Clinical trial NCT07190248: enrollment: not set → 675 participants.
BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT06926868: enrollment: not set → 500 participants.
MERCK & CO., INC. (MRK)
Clinical trial NCT06170788: enrollment: not set → 614 participants.
MERCK & CO., INC. (MRK)
Clinical trial NCT05458297: enrollment: not set → 189 participants.
NOVARTIS AG (NVSEF)
Clinical trial NCT05142696: enrollment: not set → 24 participants.
BAYER A.G. (BAYZF)
Clinical trial NCT07395804 updates: 1. completion date: 2031-02-28 → 2031-02-15 2. primary completion date: 2031-02-28 → 2031-02-15 3. enrollment: not set → 500 participants
BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT07276815: enrollment: not set → 136 participants.
AGIOS PHARMACEUTICALS, INC. (AGIO)
Clinical trial NCT03481738: enrollment: not set → 500 participants.
ABBOTT LABORATORIES (ABT)
Clinical trial NCT07271043: enrollment: not set → 60 participants.
REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07175428: enrollment: not set → 1200 participants.